US Patent 11078271 Anti-claudin-2 monoclonal antibody

Patent 11078271 was granted and assigned to Osaka University on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Osaka University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110782710

Patent Inventor Names

Minoru Tada0

Masayoshi Fukasawa0

Masuo Kondoh0

Akihiro Watari0

Jun Kunisawa0

Kiyohito Yagi0

Date of Patent

August 3, 2021

Patent Application Number

201712250

Date Filed

December 25, 2017

Patent abstract

An object of the present invention is to provide a monoclonal antibody that recognizes an extracellular region of Claudin-2. A monoclonal antibody that specifically binds to an extracellular region of Claudin-2.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11078271 Anti-claudin-2 monoclonal antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API